Pliant Therapeutics, Inc.
PLRX
$1.15
$0.021.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -92.29M | -113.22M | -149.34M | -175.50M | -206.96M |
| Total Depreciation and Amortization | 1.31M | 1.51M | 1.70M | 1.79M | 1.89M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.32M | 29.58M | 35.25M | 37.58M | 40.76M |
| Change in Net Operating Assets | -5.24M | -16.57M | -15.94M | -22.08M | -5.09M |
| Cash from Operations | -70.90M | -98.70M | -128.34M | -158.21M | -169.40M |
| Capital Expenditure | 0.00 | -112.00K | -374.00K | -583.00K | -1.48M |
| Sale of Property, Plant, and Equipment | 274.00K | 257.00K | 155.00K | 156.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 40.81M | 60.93M | 134.51M | 172.08M | 176.17M |
| Cash from Investing | 41.08M | 61.08M | 134.29M | 171.65M | 174.69M |
| Total Debt Issued | -- | -- | -- | 1.00K | 1.00K |
| Total Debt Repaid | -32.27M | -32.27M | -32.27M | -- | -- |
| Issuance of Common Stock | 146.00K | 146.00K | 570.00K | 671.00K | 1.14M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -32.12M | -32.12M | -31.70M | 672.00K | 1.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -61.94M | -69.75M | -25.74M | 14.12M | 6.43M |